Cargando…

Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation

PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Xue, Ye, Dan, Shi, Yuxun, Fan, Matthew, Lu, Peng, Feng, Yanlin, Hu, Chenyang, Liao, Jing, Cui, Kaixuan, Tang, Xiaoyu, Wu, Peiqi, Xu, Fan, Xu, Yue, Huang, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148658/
https://www.ncbi.nlm.nih.gov/pubmed/37099021
http://dx.doi.org/10.1167/iovs.64.4.31
_version_ 1785035020529827840
author Bai, Xue
Ye, Dan
Shi, Yuxun
Fan, Matthew
Lu, Peng
Feng, Yanlin
Hu, Chenyang
Liao, Jing
Cui, Kaixuan
Tang, Xiaoyu
Wu, Peiqi
Xu, Fan
Xu, Yue
Huang, Jingjing
author_facet Bai, Xue
Ye, Dan
Shi, Yuxun
Fan, Matthew
Lu, Peng
Feng, Yanlin
Hu, Chenyang
Liao, Jing
Cui, Kaixuan
Tang, Xiaoyu
Wu, Peiqi
Xu, Fan
Xu, Yue
Huang, Jingjing
author_sort Bai, Xue
collection PubMed
description PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence information regulator 1 (Sirt1). Here, we investigated whether SRT2104 could protect the retina from ischemia/reperfusion (I/R) injury and the underlying mechanisms. METHODS: SRT2104 was intravitreally injected immediately after I/R induction. RNA and protein expression were detected by quantitative real-time PCR and Western blot. Protein expression and distribution were examined by immunofluorescence staining. Retinal structure and function were analyzed by hematoxylin and eosin staining, optical coherence tomography, and electroretinogram. Optic nerve axons were quantified using toluidine blue staining. Cellular apoptosis and senescence were evaluated by TUNEL assay and SA-β-gal staining. RESULTS: The protein expression of Sirt1 decreased dramatically after I/R injury and SRT2104 administration effectively enhanced the stability of Sirt1 protein without significantly influencing Sirt1 mRNA synthesis. SRT2104 administration alone exerted no influence on the structure and function of normal retinas. However, SRT2104 intervention significantly protected the inner retinal structure and neurons; partially restored retinal function after I/R injury. I/R-induced cellular apoptosis and senescence were effectively alleviated by SRT2104 administration. Additionally, SRT2104 intervention markedly reduced neuroinflammation, including reactive gliosis, retinal vascular inflammation, and the overexpression of pro-inflammatory cytokines after I/R injury. Mechanistically, I/R-induced acetylation of p53, NF-κB p65, and STAT3 was significantly reversed by SRT2104 intervention. CONCLUSIONS: We demonstrated that SRT2104 exerted potent protective effects against I/R injury by enhancing Sirt1-mediated deacetylation and suppressing apoptosis, senescence, and neuroinflammation-related pathways.
format Online
Article
Text
id pubmed-10148658
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-101486582023-04-30 Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation Bai, Xue Ye, Dan Shi, Yuxun Fan, Matthew Lu, Peng Feng, Yanlin Hu, Chenyang Liao, Jing Cui, Kaixuan Tang, Xiaoyu Wu, Peiqi Xu, Fan Xu, Yue Huang, Jingjing Invest Ophthalmol Vis Sci Glaucoma PURPOSE: Strategies for neuroprotection are the main targets of glaucoma research. The neuroprotective properties of SRT2104 administration have been proven in central nervous system degeneration diseases through the activation of nicotinamide adenine dinucleotide-dependent deacetylase-silence information regulator 1 (Sirt1). Here, we investigated whether SRT2104 could protect the retina from ischemia/reperfusion (I/R) injury and the underlying mechanisms. METHODS: SRT2104 was intravitreally injected immediately after I/R induction. RNA and protein expression were detected by quantitative real-time PCR and Western blot. Protein expression and distribution were examined by immunofluorescence staining. Retinal structure and function were analyzed by hematoxylin and eosin staining, optical coherence tomography, and electroretinogram. Optic nerve axons were quantified using toluidine blue staining. Cellular apoptosis and senescence were evaluated by TUNEL assay and SA-β-gal staining. RESULTS: The protein expression of Sirt1 decreased dramatically after I/R injury and SRT2104 administration effectively enhanced the stability of Sirt1 protein without significantly influencing Sirt1 mRNA synthesis. SRT2104 administration alone exerted no influence on the structure and function of normal retinas. However, SRT2104 intervention significantly protected the inner retinal structure and neurons; partially restored retinal function after I/R injury. I/R-induced cellular apoptosis and senescence were effectively alleviated by SRT2104 administration. Additionally, SRT2104 intervention markedly reduced neuroinflammation, including reactive gliosis, retinal vascular inflammation, and the overexpression of pro-inflammatory cytokines after I/R injury. Mechanistically, I/R-induced acetylation of p53, NF-κB p65, and STAT3 was significantly reversed by SRT2104 intervention. CONCLUSIONS: We demonstrated that SRT2104 exerted potent protective effects against I/R injury by enhancing Sirt1-mediated deacetylation and suppressing apoptosis, senescence, and neuroinflammation-related pathways. The Association for Research in Vision and Ophthalmology 2023-04-26 /pmc/articles/PMC10148658/ /pubmed/37099021 http://dx.doi.org/10.1167/iovs.64.4.31 Text en Copyright 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Glaucoma
Bai, Xue
Ye, Dan
Shi, Yuxun
Fan, Matthew
Lu, Peng
Feng, Yanlin
Hu, Chenyang
Liao, Jing
Cui, Kaixuan
Tang, Xiaoyu
Wu, Peiqi
Xu, Fan
Xu, Yue
Huang, Jingjing
Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title_full Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title_fullStr Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title_full_unstemmed Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title_short Neuroprotection of SRT2104 in Murine Ischemia/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation
title_sort neuroprotection of srt2104 in murine ischemia/reperfusion injury through the enhancement of sirt1-mediated deacetylation
topic Glaucoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148658/
https://www.ncbi.nlm.nih.gov/pubmed/37099021
http://dx.doi.org/10.1167/iovs.64.4.31
work_keys_str_mv AT baixue neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT yedan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT shiyuxun neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT fanmatthew neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT lupeng neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT fengyanlin neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT huchenyang neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT liaojing neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT cuikaixuan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT tangxiaoyu neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT wupeiqi neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT xufan neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT xuyue neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation
AT huangjingjing neuroprotectionofsrt2104inmurineischemiareperfusioninjurythroughtheenhancementofsirt1mediateddeacetylation